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Antibiotics are widely used in the intensive care unit 
(ICU); with approximately half of the patients diagnosed 
with an infection, this is not surprising [1]. In parallel, we 
are witnessing an increase in the incidence of infections 
caused by multidrug resistant (MDR) infections, in which 
exposure to antibiotics is a contributing factor [2].
Hospital-wide antibiotic stewardship programs (ASP) 
have been developed to reduce antibiotic exposure 
and improve patient outcomes. In a multidisciplinary 
approach involving different specialties, different inter-
ventions are used to assist prescribers in better antibi-
otic decision-making. This may include the provision of 
guidelines, formulary restrictions, review and feedback 
[3].
ASP meetings are widely used in the ICU [4] but the 
frequency, duration and its participants vary from daily 
meetings with the complete team discussing each patient 
to once-weekly meetings with part of the team to discuss 
the difficult to treat patients.
Despite the presence of the microbiologist in ICU is 
frequently advocated [5], and studies have reported on 
improved antimicrobial practices after establishing a 
more closer interaction between clinicians and microbi-
ologists in before–after studies in single-center studies 
[6], no study has formally demonstrated the superiority of 
a strategy with a microbiologist in daily rounds compared 
to different types of “liaisons” in ICU, nor in other set-
tings. Furthermore, the systematic review by Lane et al. 
[7], which explored facilitators and barriers for patients 
care round in ICU, did not identify the “microbiologist” 
(but the pharmacist instead!) as leading character in mul-
tidisciplinary team rounds.
Still, extensive knowledge on susceptibility patterns, 
local ecology, the importance of previous infections and 
colonization with MDR pathogens are among the core 
competencies of clinical microbiologists deemed essen-
tial for appropriate management of antimicrobial therapy 
in the ICU (Table 1).
Since the (often mandatory) introduction of ASPs in 
hospital, an increasing burden has been placed upon 
Antimicrobial Management Team members, who have 
often extended their work without being provided addi-
tional workforce or funding. This is especially true for 
microbiologists who now need to combine more clini-
cal outreach work with laboratory practice. As daily/
weekly meetings and continuous out-of-hours service are 
requested by ever more departments, the workload for 
the microbiologist is increasing. In an era where physi-
cian burnout is more prevalent than ever before, this 
should not be underestimated.
Even if daily presence of a microbiologist may be con-
sidered valuable by intensivists [5], the time efficiency of 
such meetings is obviously questionable: not all patients 
have an infectious problem or have antibiotics and—once 
the topic of infections is discussed—intensivists may lin-
ger on indefinitely about nutrition, weaning or any other 
non-infection-related (but equally important) problem 
during which the microbiologist is clearly wasting time. 
Moreover, other members of the ASP team present at the 
meeting may also be losing valuable time.
With the introduction of rapid diagnostics [8], estab-
lishing diagnosis of the causative pathogen and suscep-
tibility patterns in a matter of hours rather than days, a 
daily meeting at a fixed moment seems obsolete and 
would essentially slow down appropriate antimicrobial 
decision making. Moreover, modern communication 
technology and advanced electronic medical records 
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nowadays allow for other means of interaction between 
the microbiologist and the ICU team [9].
So, how can we find a more efficient and less time-con-
suming way to integrate valuable microbiological advice 
into modern ICU practice?
Based on the experience of the team, the availability of 
the microbiologist and the needs of the unit at a specific 
moment in time, a unit-tailored approach can be prefer-
able. In recently started ASP teams, daily meetings with 
the whole team may be very valuable, but, as experience 
of the team grows, antibiotic therapy is settled in clear 
local guidelines, laboratory is 24/7 and a microbiologist 
is available on call for the most rapid communication 
process of microbiology results to ICU team—the role of 
daily meetings may change. In a mature ASP team, meet-
ings should be used to reinforce knowledge and strategies 
as well as to introduce new concepts or discuss ecology, 
etc. At that stage, much of the antimicrobial prescrip-
tions are covered by guidelines and standard practices 
which are now very familiar to the bedside team.
We remain convinced that face-to-face contact is 
essential for implementation of good antimicrobial stew-
ardship. While day-to-day immediate feedback using 
modern information technology solutions is now feasible 
and effective, we must keep seeing the microbiologist in 
our ICU in person on a regular basis (but not necessarily 
daily during ICU rounds) to (Table 1):
  • Learn about our prescribing patterns related to 
(changing) resistance patterns in our ICU unit.
  • Learn about new developments in (rapid) diagnostics 
and their effect in relevant antimicrobial stewardship 
principles in ICU.
  • Assist in interpretation of results or in reducing 
unnecessary testing.
Conversely, microbiologists must be exposed regularly 
to the clinical complexities in ICU to improve their inte-
grative consultation skills and regular interaction with 
intensivists will facilitate this.
We advocate the adoption of an alternative scheduling 
of appointments with clinical microbiologists and other 
ASP team members as below:
  • Once weekly clinical round in which difficult-to-treat 
patients are discussed with the microbiologist.
  • Once per 3–6 months feedback session with data on 
adherence to appropriate prescribing (using relevant 
quality indicators for antimicrobial prescribing in 
ICU such as guideline adherence, appropriate dura-
tion and PK-PD) and an oversight of hospital-wide 
emergence of MDR pathogens.
  • More frequent (and even daily) meetings during out-
breaks or epidemics requiring close collaboration and 
with need for intensified infection control measures.
In conclusion, the importance of a microbiologist with 
his/her knowledge based in the management of ICU 
infections is undisputed. However, in this era of modern 
communication tools, physical presence of a microbiolo-
gist at a daily face-to-face ward round may not be needed 
once an ICU antimicrobial stewardship program is fully 
established. We support the use of continuous digital 
microbiological support and established ICU adapted 
guidelines on one hand and a more flexible face-to-face 
approach when dedicated advice is really needed. 24/7 
Table 1 Overview of areas of expertise and involvement of the clinical microbiologist in the ICU
Core domains of the clinical microbiologist in ICU Frequency Activities (other than daily rounds)
Assisting physicians in diagnosis and empirical treatment Daily On-call availability, rapid results communication and consulta-
tion, guidelines development
Aiding in interpretation of results Daily Report with note for contamination/colonization, selective 
reporting on antimicrobial susceptibilities, educational 
meeting
Avoiding unnecessary testing Daily Educational campaigns, audit and feedback, electronic order-
ing implementation
Assisting in correct microbiological sampling techniques and 
timing thereof
Daily On-call availability, guidelines development, educational 
meetings on new and advanced diagnostic tests
Assisting in selecting the optimal targeted antibiotic and the 
correct duration
From daily to weekly Periodical meetings, on-call availability, selective reporting 
of antibiotic susceptibilities, computer-decision support 
system, guidelines development
Providing cumulative surveillance data on resistant organisms 
for infection control purposes
From every 3 months 
or 6 months to 
1 year
Hospital intranet, printed card, educational meeting
Facilitating infection prevention and control practices Daily On-call availability, guidelines development, educational 
meetings
availability of an (on call) microbiologist to validate rapid 
diagnostic testing is essential to allow for fast change 
of therapy. We do believe that structural (not daily but 
weekly or monthly) meetings are warranted to keep both 
parties aligned.
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